| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ATHA | Athira Pharma, Inc. | Worthington Mark | GENERAL COUNSEL | Jan 05, 2024 | Sale | $2.91 | 2,412 | 7,019 | 34,452 | Feb 16, 2024, 04:37 PM | |
| ATHA | Athira Pharma, Inc. | Worthington Mark | GENERAL COUNSEL | May 18, 2023 | Option Exercise | $2.41 | 7,767 | 18,718 | 26,864 | Feb 16, 2024, 04:37 PM | |
| ATHA | Athira Pharma, Inc. | Worthington Mark | General Counsel | May 18, 2023 | Option Exercise | $2.41 | 7,767 | 18,718 | 26,864 | Jan 08, 2024, 04:38 PM | |
| ATHA | Athira Pharma, Inc. | Worthington Mark | General Counsel | Jan 05, 2024 | Sale | $2.91 | 2,412 | 7,019 | 34,452 | Jan 08, 2024, 04:38 PM | |
| ATHA | Athira Pharma, Inc. | Worthington Mark | General Counsel | May 18, 2022 | Option Exercise | $7.06 | 3,396 | 23,976 | 11,711 | Jun 24, 2022, 07:55 PM | |
| ATHA | Athira Pharma, Inc. | Worthington Mark | General Counsel | Jun 23, 2022 | Sale | $2.69 | 2,614 | 7,032 | 19,097 | Jun 24, 2022, 07:55 PM |
Menu